PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

E-ISSN： 1873-4286|17|2|137-150

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.2, 2011-01, pp. : 137-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 10A inhibitors as a novel therapeutic approach for schizophrenia

By Siuciak Judith A Strick Christine A

Expert Opinion on Drug Discovery, Vol. 2, Iss. 7, 2007-07 ,pp. : 1001-1009

Informa Healthcare

Access to resources Recommend Favorite

Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 177-182

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of PDE4 inhibitors

By Dyke H.J. Montana J.G.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1327-1327

Informa Healthcare

Access to resources Recommend Favorite

D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy

Current Pharmaceutical Design, Vol. 19, Iss. 14, 2013-04 ,pp. : 2499-2511

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Targets for Drugs in Schizophrenia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite